- Testimony of
Robert M. Califf, M.D., MACC
Commissioner of Food and Drugs - Food and Drug Administration
Chair Murray, Ranking Member Burr, distinguished members of the Committee, thank you for this opportunity to testify before you today to describe the Food and Drug Administration’s (FDA’s or the Agency’s) monkeypox disease response efforts. All of our efforts are in close coordination and collaboration with our partners, both within the Department of Health and Human Services (HHS) and across the federal government, to help ensure the development, authorization, licensure, approval, and availability of critical, safe, and effective medical products to address the monkeypox virus public health emergency.